Dudediligence.

Rhythm Pharmaceuticals, Inc

RYTMNASDAQ · Pharmaceutical Preparations
Write an idea

Price
OptionsOpen the Sheet →FilingsNewest: 10-Q, Quarterly reportAug 4 →InsidersNo open-market buys. 5 insiders sold $12.9M, 33 of 35 sales on a 10b5-1 plan.→HoldersRa 9.7%BlackRock 8.9%Baker Bros 8.1%→Financing →PeersClosest companies: BHVN, ZBIO, SRRK→

From the filings

Figures

Revenue
$239.9Mlast 12 months
Net income
−$9.0Mlast 12 months
Operating cash flow
−$119.5Mlast 12 months
Cash and equivalents
$65.6Mat the last balance sheet
Total debt
$106.1Mat the last balance sheet
Shares outstanding
68.8M shareson issue
Every year and quarter →